Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
sotagliflozin
Pharma
Lexicon gets final FDA rejection for diabetes prospect
The company already moved to cut its commercial sales force following several FDA setbacks in its efforts to introduce sotagliflozin in diabetes.
Zoey Becker
Dec 23, 2024 11:20am
FDA expert panel spurns Lexicon's approval bid in type 1 diabetes
Nov 1, 2024 11:24am
Viatris lays out $25M to tackle marketing of Lexicon's Inpefa
Oct 17, 2024 10:17am
In restructuring move, Lexicon to lay off 50% of field force
Aug 13, 2024 3:34pm
Lexicon preps FDA resubmission for diabetes hopeful Zynquista
Mar 12, 2024 7:15am
Lexicon poaches BMS' Tom Garner as new commercial lead
Oct 10, 2023 9:45am